ClinicalTrials.Veeva

Menu

Physical Exam Indicated Cerclage in Twin Gestations (TWIN-PEIC)

Thomas Jefferson University logo

Thomas Jefferson University

Status

Terminated

Conditions

Twin Pregnancy, Antepartum Condition or Complication
Cervical Dilation Premature
Preterm Birth

Treatments

Procedure: Physical exam indicated cerclage

Study type

Interventional

Funder types

Other

Identifiers

NCT02490384
ThomasJeffersonU

Details and patient eligibility

About

This is a multicenter randomized study designed to determine if physical exam indicated cerclage reduces the incidence of spontaneous preterm birth <34 weeks in asymptomatic women with twin gestations and dilated cervix, diagnosed by pelvic exam between 16 to 23 6/7 weeks of gestation.

Full description

Twin pregnancies have 58% incidence of preterm delivery (before 37 weeks of gestation), with increased perinatal mortality and neonatal morbidity. No therapy has proven effective in preventing preterm birth in twins. When cervical dilation is identified before 24 weeks in singleton pregnancies, the risk of preterm birth is 90%-100%; based on a small series of cases, approximately 50% of twin gestations with cervical dilation will be delivered prior to viability (24 weeks) and the risk of preterm birth prior to 34 and 37 weeks was 85% and 100%. Cervical dilation is the worst prognostic factor for preterm birth. There are a small number of case reports of cervical cerclage in twin pregnancies with a dilated cervix that suggest similar outcomes to those in singleton pregnancies. The investigators' objective is to determine if physical exam indicated cerclage reduces the incidence of spontaneous preterm birth <34 weeks and improve perinatal outcome in asymptomatic women with twin gestations and dilated cervix (1 to 5 cm) between 16 to 23 6/7 weeks of gestation.

Enrollment

30 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Pregnant women older than 18 years of age
  2. Diamniotic twin pregnancy
  3. Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or speculum exam between at 16-23 6/7 weeks gestation

Exclusion criteria

  1. Singleton pregnancy or higher order than twins multiple gestation
  2. Cervical dilation more than 5 cm
  3. Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize cervical tissue
  4. More than 24 weeks of gestation
  5. Multifetal reduction after 14 weeks
  6. Monoamniotic twins
  7. Twin-twin transfusion syndrome
  8. Ruptured amniotic membranes at the time of diagnosis of dilated cervix
  9. Major fetal structural anomaly
  10. Fetal chromosomal abnormality
  11. Cerclage already in place for other indications
  12. Active vaginal bleeding
  13. Suspicion of clinical or biochemical chorioamnionitis
  14. Painful regular uterine contractions
  15. Labor (progressing cervical dilation)
  16. Placenta previa

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Physical exam indicated cerclage
Active Comparator group
Description:
Cerclage
Treatment:
Procedure: Physical exam indicated cerclage
Expectant management
No Intervention group
Description:
No cerclage

Trial documents
2

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems